Analyst Activity – Needham & Company LLC Raises Its Price Target On CONMED (NASDAQ:CNMD) to $71.00

ME Staff
-
0

Analyst Ratings For CONMED (NASDAQ:CNMD)

Today, Needham & Company LLC raised its price target on CONMED (NASDAQ:CNMD) to $71.00 per share.

Some recent analyst ratings include

  • 11/3/2017-KeyCorp Reiterated Rating of Hold.
  • 11/3/2017-Piper Jaffray Companies Reiterated Rating of Hold.
  • 4/27/2017-Ladenburg Thalmann Financial Services was Downgraded by analysts at Ladenburg Thalmann Financial Services from a “Buy ” rating to a ” Neutral” rating. They now have a $48.00 price target on the stock, up previously from $50.00 .
  • 11/23/2016-Leerink Swann Reiterated Rating of Hold .

Dividend information for CONMED (NASDAQ:CNMD)

CONMED (NASDAQ:CNMD) pays an annual dividend of $0.80 with a yield of 1.28%.

Dividend History for CONMED (NASDAQ:CNMD)

  • On 11/28/2017 CONMED announced a quarterly dividend of $0.20 1.48% with an ex dividend date of 12/14/2017 which will be payable on 1/5/2018.
  • On 8/29/2017 CONMED announced a quarterly dividend of $0.20 1.65% with an ex dividend date of 9/14/2017 which will be payable on 10/5/2017.
  • On 5/24/2017 CONMED announced a quarterly dividend of $0.20 1.6% with an ex dividend date of 6/13/2017 which will be payable on 7/5/2017.
  • On 2/28/2017 CONMED announced a quarterly dividend of $0.20 1.92% with an ex dividend date of 3/13/2017 which will be payable on 4/5/2017.
  • On 11/21/2016 CONMED announced a quarterly dividend of $0.20 1.77% with an ex dividend date of 12/13/2016 which will be payable on 1/5/2017.
  • On 8/25/2016 CONMED announced a quarterly dividend of $0.20 1.99% with an ex dividend date of 9/13/2016 which will be payable on 10/5/2016.
  • On 5/25/2016 CONMED announced a quarterly dividend of $0.20 2.05% with an ex dividend date of 6/13/2016 which will be payable on 7/6/2016.

Recent Insider Trading Activity For CONMED (NASDAQ:CNMD)
CONMED (NASDAQ:CNMD) has insider ownership of 2.62% and institutional ownership of 99.05%.

  • On 1/3/2018 Charles Farkas, Director, bought 158 with an average share price of $50.61 per share and the total transaction amounting to $7,996.38.
  • On 11/9/2017 Luke A Pomilio, EVP, sold 29,363 with an average share price of $50.70 per share and the total transaction amounting to $1,488,704.10.
  • On 11/7/2017 Luke A Pomilio, CFO, sold 12,429 with an average share price of $50.63 per share and the total transaction amounting to $629,280.27.
  • On 11/3/2017 Luke A Pomilio, EVP, sold 10,020 with an average share price of $53.57 per share and the total transaction amounting to $536,771.40.
  • On 10/3/2017 Charles Farkas, Director, bought 148 with an average share price of $53.96 per share and the total transaction amounting to $7,986.08.
  • On 8/14/2017 Jo Ann Golden, Director, sold 3,000 with an average share price of $50.00 per share and the total transaction amounting to $150,000.00.
  • On 7/5/2017 Charles Farkas, Director, bought 157 with an average share price of $50.78 per share and the total transaction amounting to $7,972.46.

Recent Trading Activity for CONMED (NASDAQ:CNMD)
Shares of CONMED closed the previous trading session at 62.84 up +5.06 8.76% with 196455 shares trading hands.